Literature DB >> 28479335

Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.

Oliver T Burton1, Jaciel M Tamayo2, Amanda J Stranks2, Kyle J Koleoglou3, Hans C Oettgen2.   

Abstract

BACKGROUND: Patients with food allergy produce high-titer IgE antibodies that bind to mast cells through FcεRI and trigger immediate hypersensitivity reactions on antigen encounter. Food-specific IgG antibodies arise in the setting of naturally resolving food allergy and accompany the acquisition of food allergen unresponsiveness in oral immunotherapy.
OBJECTIVE: In this study we sought to delineate the effects of IgG and its inhibitory Fc receptor, FcγRIIb, on both de novo allergen sensitization in naive animals and on established immune responses in the setting of pre-existing food allergy.
METHODS: Allergen-specific IgG was administered to mice undergoing sensitization and desensitization to the model food allergen ovalbumin. Cellular and molecular mechanisms were interrogated by using mast cell- and FcγRIIb-deficient mice. The requirement for FcγRII in IgG-mediated inhibition of human mast cells was investigated by using a neutralizing antibody.
RESULTS: Administration of specific IgG to food allergy-prone IL4raF709 mice during initial food exposure prevented the development of IgE antibodies, TH2 responses, and anaphylactic responses on challenge. When given as an adjunct to oral desensitization in mice with established IgE-mediated hypersensitivity, IgG facilitated tolerance restoration, favoring expansion of forkhead box protein 3-positive regulatory T cells along with suppression of existing TH2 and IgE responses. IgG and FcγRIIb suppress adaptive allergic responses through effects on mast cell function.
CONCLUSION: These findings suggest that allergen-specific IgG antibodies can act to induce and sustain immunologic tolerance to foods.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FcγRIIb; IgG; Mast cell; food allergy; oral immunotherapy; regulatory T cell; tolerance

Mesh:

Substances:

Year:  2017        PMID: 28479335      PMCID: PMC5671359          DOI: 10.1016/j.jaci.2017.03.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  76 in total

1.  Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB.

Authors:  O Malbec; W H Fridman; M Daëron
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.

Authors:  Nadine van Montfoort; Peter A C 't Hoen; Sara M Mangsbo; Marcel G M Camps; Peter Boross; Cornelis J M Melief; Ferry Ossendorp; J Sjef Verbeek
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

3.  Important role for FcγRIIB on B lymphocytes for mucosal antigen-induced tolerance and Foxp3+ regulatory T cells.

Authors:  Jia-Bin Sun; Zou Xiang; Kenneth G C Smith; Jan Holmgren
Journal:  J Immunol       Date:  2013-09-13       Impact factor: 5.422

4.  A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody.

Authors:  L M Lichtenstein; N A Holtzman; L S Burnett
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

5.  A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.

Authors:  Daocheng Zhu; Christopher L Kepley; Min Zhang; Ke Zhang; Andrew Saxon
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

6.  Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.

Authors:  Holly M Horton; Seung Y Chu; Elizabeth C Ortiz; Erik Pong; Saso Cemerski; Irene W L Leung; Noam Jacob; Jonathan Zalevsky; John R Desjarlais; William Stohl; David E Szymkowski
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

7.  Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells.

Authors:  K Suzuki; H Nakajima; N Watanabe; S i Kagami; A Suto; Y Saito; T Saito; I Iwamoto
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

8.  Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids.

Authors:  G Krishnaswamy; T Lakshman; A R Miller; S Srikanth; K Hall; S K Huang; J Suttles; J K Smith; R Stout
Journal:  J Interferon Cytokine Res       Date:  1997-03       Impact factor: 2.607

9.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Int Immunol       Date:  2007-06-22       Impact factor: 4.823

10.  Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Authors:  Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-02-20       Impact factor: 3.406

View more
  30 in total

1.  Origins of peanut allergy-causing antibodies.

Authors:  Duane R Wesemann; Cathryn R Nagler
Journal:  Science       Date:  2020-03-06       Impact factor: 47.728

Review 2.  Recent developments in understanding the mechanisms of food allergy.

Authors:  Zoe C Schmiechen; Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

Review 3.  Immune mechanisms of oral immunotherapy.

Authors:  Michael D Kulis; Sarita U Patil; Erik Wambre; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2017-12-26       Impact factor: 10.793

Review 4.  Novel vaccines: Technology and development.

Authors:  Sarita U Patil; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2018-06-30       Impact factor: 10.793

Review 5.  Mechanisms of Oral Tolerance.

Authors:  Leticia Tordesillas; M Cecilia Berin
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 6.  The Multifaceted B Cell Response in Allergen Immunotherapy.

Authors:  Rodrigo Jiménez-Saiz; Sarita U Patil
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-05       Impact factor: 4.806

Review 7.  Emerging Food Allergy Biomarkers.

Authors:  Sarita U Patil; Supinda Bunyavanich; M Cecilia Berin
Journal:  J Allergy Clin Immunol Pract       Date:  2020-09

8.  Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.

Authors:  Shiteng Duan; Britni M Arlian; Corwin M Nycholat; Yadong Wei; Hiroaki Tateno; Scott A Smith; Matthew S Macauley; Zhou Zhu; Bruce S Bochner; James C Paulson
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.422

Review 9.  Oral immunotherapy for food allergy.

Authors:  Deborah M Hussey Freeland; Monali Manohar; Sandra Andorf; Benjamin D Hobson; Wenming Zhang; Kari C Nadeau
Journal:  Semin Immunol       Date:  2017-08-31       Impact factor: 11.130

Review 10.  B cells and food allergy.

Authors:  Chioma Udemgba; Adora Lin
Journal:  Curr Opin Pediatr       Date:  2021-12-01       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.